Berman Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $138K | Sell |
761
-10
| -1% | -$1.81K | 0.02% | 353 |
|
|
2021
Q2 | $154K | Buy |
771
+271
| +54% | +$54.1K | 0.02% | 278 |
|
|
2021
Q1 | $107K | Buy |
500
+146
| +41% | +$31.2K | 0.02% | 293 |
|
|
2020
Q4 | $83K | Sell |
354
-74
| -17% | -$17.4K | 0.02% | 287 |
|
|
2020
Q3 | $115K | Buy |
428
+24
| +6% | +$6.45K | 0.03% | 211 |
|
|
2020
Q2 | $117K | Buy |
404
+59
| +17% | +$17.1K | 0.03% | 204 |
|
|
2020
Q1 | $81K | Buy |
345
+77
| +29% | +$18.1K | 0.03% | 226 |
|
|
2019
Q4 | $58K | Buy |
268
+4
| +2% | +$866 | 0.02% | 298 |
|
|
2019
Q3 | $44K | Sell |
264
-2
| -0.8% | -$333 | 0.01% | 333 |
|
|
2019
Q2 | $48K | Sell |
266
-55
| -17% | -$9.93K | 0.02% | 312 |
|
|
2019
Q1 | $59K | Buy |
321
+104
| +48% | +$19.1K | 0.02% | 252 |
|
|
2018
Q4 | $35K | Buy |
+217
| New | +$35K | 0.01% | 289 |
|